resTORbio Company
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Technology:
Geroscience
Industry:
AgeTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Total Funding:
65000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership